DIN 02457350 — RITUXAN SC 1400 MG
RITUXAN SC is a solution of Rituximab marketed by HOFFMANN-LA ROCHE LIMITED. The full Rituximab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02457350
- Brand name
- RITUXAN SC
- Active ingredient
- Rituximab
- Strength
- 1400 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- HOFFMANN-LA ROCHE LIMITED
- Health Canada status
- MARKETED
- Drug class
- Anti-CD20 monoclonal antibody (antineoplastic/immunosuppressive agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Rituximab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02241927 | RITUXAN | 10 MG | SOLUTION | HOFFMANN-LA ROCHE LIMITED | MARKETED |
| 02473976 | RITUXAN SC | 1600 MG | SOLUTION | HOFFMANN-LA ROCHE LIMITED | MARKETED |
| 02498316 | RIXIMYO | 10 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02495724 | RUXIENCE | 10 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |
| 02478382 | TRUXIMA | 100 MG | SOLUTION | CELLTRION INC. | MARKETED |
| 02478390 | TRUXIMA | 500 MG | SOLUTION | CELLTRION INC. | MARKETED |